Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
6.22
+0.24 (4.01%)
At close: Mar 23, 2026, 4:00 PM EDT
6.02
-0.20 (-3.22%)
After-hours: Mar 23, 2026, 5:14 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $15.76 million as of March 23, 2026. Its market cap has decreased by -54.83% in one year.
Market Cap
15.76M
Enterprise Value
8.41M
1-Year Change
-54.83%
Ranking
Category
Stock Price
$6.22
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $15.76M, a decrease of -76.12%. That is a compound annual growth rate of -40.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 15.15M | -38.50% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Citius Pharmaceuticals | 17.02M |
| FibroBiologics | 16.98M |
| IN8bio | 16.40M |
| Lixte Biotechnology Holdings | 15.40M |
| AEON Biopharma | 15.32M |
| Cocrystal Pharma | 14.96M |
| Phio Pharmaceuticals | 14.52M |
| GT Biopharma | 14.26M |